Cargando…
Re-highlighting the action of PPARγ in treating metabolic diseases
Peroxisome proliferator-activated receptor γ (PPARγ) is a member of the nuclear receptor family and plays an important role in adipocyte differentiation, glucose homeostasis, and insulin sensitivity. Thiazolidinediones (TZDs), synthetic ligands of PPARγ, have been used for the treatment of diabetes...
Autores principales: | Choi, Sung Hee, Chung, Sung Soo, Park, Kyong Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058466/ https://www.ncbi.nlm.nih.gov/pubmed/30079233 http://dx.doi.org/10.12688/f1000research.14136.1 |
Ejemplares similares
-
F-box only protein 9 is an E3 ubiquitin ligase of PPARγ
por: Lee, Kyeong Won, et al.
Publicado: (2016) -
The Role of PPARγ in Helicobacter pylori Infection and Gastric Carcinogenesis
por: Lee, Jong-Min, et al.
Publicado: (2012) -
Revisiting PPARγ as a target for the treatment of metabolic disorders
por: Choi, Sun-Sil, et al.
Publicado: (2014) -
Protective Actions of PPAR-γ Activation in Renal Endothelium
por: Westerweel, Peter E., et al.
Publicado: (2008) -
Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system
por: Toffoli, Barbara, et al.
Publicado: (2017)